Pharmaceutical Nanotechnology,volume 3,issue 4  (03-2016)

Period of time： 2016年4期

Publisher： Bentham Science Publishers

Founded in： 2013

Total resources： 20

E-ISSN： 2211-7393|3|4

ISSN： 2211-7385

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Pharmaceutical Nanotechnology,volume 3,issue 4

Menu

Editorial:

Pharmaceutical Nanotechnology,volume 3,issue 4 , Vol. 3, Iss. 4, 2016-03 , pp. 223-223

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Editorial (Thematic Issue: Advances in Pharmaceutical Nanotechnology and Nanomedicine)

Pharmaceutical Nanotechnology,volume 3,issue 4 , Vol. 3, Iss. 4, 2016-03 , pp. 224-227

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Technologies for the Evaluation of Efficacy of Nanoformulation for Removal of Radiological Contamination

Pharmaceutical Nanotechnology,volume 3,issue 4 , Vol. 3, Iss. 4, 2016-03 , pp. 228-238

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Dendrimer-drug Conjugates in Drug Delivery and Targeting

Pharmaceutical Nanotechnology,volume 3,issue 4 , Vol. 3, Iss. 4, 2016-03 , pp. 239-260

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Modified Polysaccharides as Carriers for Biomolecules

Pharmaceutical Nanotechnology,volume 3,issue 4 , Vol. 3, Iss. 4, 2016-03 , pp. 261-287

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Utilising Nanotechnology and Nanosystems for Treatment of Rare Diseases

Pharmaceutical Nanotechnology,volume 3,issue 4 , Vol. 3, Iss. 4, 2016-03 , pp. 288-305

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Stability Testing During Development of Nanopharmaceuticals

Pharmaceutical Nanotechnology,volume 3,issue 4 , Vol. 3, Iss. 4, 2016-03 , pp. 306-314

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Dendrimer Based Formulation of Erlotiniib HCl: Development, Characterization and In-Vitro Evaluation

Pharmaceutical Nanotechnology,volume 3,issue 4 , Vol. 3, Iss. 4, 2016-03 , pp. 315-321

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

SiRNA Mediated Gene Silencing: Hurdles, Strategies and Applications

Pharmaceutical Nanotechnology,volume 3,issue 4 , Vol. 3, Iss. 4, 2016-03 , pp. 322-333

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

ACKNOWLEDGEMENTS TO REVIEWERS

Pharmaceutical Nanotechnology,volume 3,issue 4 , Vol. 3, Iss. 4, 2016-03 , pp. 334-335

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 10 item(s)